CAPTRUST Financial Advisors’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,804
Closed -$13.1K – 3462
2026
Q2
$13.1K Buy
+15,804
New +$14.5K ﹤0.01% 3230
2024
Q2
– Sell
-12,359
Closed -$100K – 2214
2024
Q1
$100K Sell
12,359
-1,309
-10% -$11.6K ﹤0.01% 2057
2023
Q4
$136K Sell
13,668
-15,142
-53% -$119K ﹤0.01% 2482
2023
Q3
$230K Buy
28,810
+9,927
+53% +$100K ﹤0.01% 2194
2023
Q2
$208K Buy
18,883
+6,310
+50% +$65K ﹤0.01% 2241
2023
Q1
$130K Buy
12,573
+1,333
+12% +$15.7K ﹤0.01% 2125
2022
Q4
$124K Buy
+11,240
New +$144K ﹤0.01% 2026
2022
Q3
– Sell
-4,720
Closed -$108K – 2554
2022
Q2
$108K Buy
4,720
+4,528
+2,358% +$96.9K ﹤0.01% 2142
2022
Q1
$5K Buy
192
+172
+860% +$3.88K ﹤0.01% 4143
2021
Q4
$1K Buy
+20
New +$700 ﹤0.01% 4551

Other funds holding DH

CAPTRUST Financial Advisors's DH Position: Q3 2026 in Review

CAPTRUST Financial Advisors sold out of Definitive Healthcare (DH) in Q3 2026, closing a stake of 15,804 shares — an estimated $13.1K sold.

CAPTRUST Financial Advisors first reported a position in DH in Q4 2021 and held it in 10 quarters. The position peaked at $230K in Q3 2023. 68 funds tracked by Wall St. Rank hold DH as of Q3 2026.

  • CAPTRUST Financial Advisors reported no remaining Definitive Healthcare position as of Q3 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 15,804 Definitive Healthcare shares in Q3 2026, an estimated $13.1K.
  • CAPTRUST Financial Advisors first reported a position in Definitive Healthcare in Q4 2021 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Definitive Healthcare position peaked at $230K in Q3 2023.
  • 68 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.